1 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.57% |
2 | EXEL | Exelixis, Inc. | 2.51% |
3 | INSM | Insmed Incorporated | 2.50% |
4 | INCY | Incyte Corporation | 2.48% |
5 | UTHR | United Therapeutics Corporation | 2.48% |
6 | NBIX | Neurocrine Biosciences, Inc. | 2.46% |
7 | NTRA | Natera, Inc. | 2.43% |
8 | REGN | Regeneron Pharmaceuticals, Inc. | 2.42% |
9 | MRNA | Moderna, Inc. | 2.39% |
10 | GILD | Gilead Sciences, Inc. | 2.37% |
11 | VRTX | Vertex Pharmaceuticals Incorporated | 2.36% |
12 | ABBV | AbbVie Inc. | 2.35% |
13 | HALO | Halozyme Therapeutics, Inc. | 2.35% |
14 | AMGN | Amgen Inc. | 2.31% |
15 | BIIB | Biogen Inc. | 2.30% |
16 | BMRN | BioMarin Pharmaceutical Inc. | 2.28% |
17 | EXAS | Exact Sciences Corporation | 2.24% |
18 | BBIO | BridgeBio Pharma, Inc. | 2.23% |
19 | BPMC | Blueprint Medicines Corporation | 1.95% |
20 | MDGL | Madrigal Pharmaceuticals, Inc. | 1.84% |
21 | TGTX | TG Therapeutics, Inc. | 1.79% |
22 | ROIV | Roivant Sciences Ltd. | 1.72% |
23 | IONS | Ionis Pharmaceuticals, Inc. | 1.44% |
24 | CYTK | Cytokinetics, Incorporated | 1.44% |
25 | RVMD | Revolution Medicines, Inc. | 1.44% |
View XBI holdings |